doi:10.1210/en.2004-1286 ConjuChem
In SURMOUNT-1, adults with obesity (without diabetes) lost an average of 15.0%, 19.5%, and 20.9% of body weight with tirzepatide 5 mg, 10 mg, and 15 mg respectively over 72 weeks, compared to 3.1% with placebo
Exp Hematol 37:151158 Liu Y, Pop R, Sadegh C, Brugnara C, Haase VH, Socolovsky M (2006) Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo
Hexarelin is a synthetic growth hormone-releasing peptide known for its protective properties within the cardiovascular and nervous systems, along with its ability to stimulate growth
In contrast, the free QCN gel showed weaker shear-thinning (28 Pas 1.5 Pas), lacking supramolecular organization and thus being more prone to phase separation
Zhou X, Sun H, Ellen TP, Chen H, Costa M